 |
 |
 |
| |
Conference Agenda at-a-glance |
DAY ONE:
Tuesday June 10th, 2008 |
| |
7:30 AM |
Registration Opens |
| |
| |
8:15 AM |
Opening Remarks From The Chairperson |
| |
| |
8:30 AM |
Keynote Address |
Health Canada’s Perspective On Subsequent-Entry Biologics: Demonstrating Comparability And Other Regulatory Issues |
 |
Anthony Ridgway, Ph.D., Senior Regulatory Scientist, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics, BGTD, Health Canada |
| |
| |
9:15 AM |
Progressive Licensing Framework |
Towards An Integrated Benefit-Risk-Based Approach To Licensing Biologics |
|
Dr. Robyn Lim, Progressive Licensing Project, Therapeutic Products Directorate, Health Canada |
| |
| |
10:00 AM |
Networking Break |
| |
| |
10:30 AM |
Key Strategies For Advancing The Innovation Agenda For Canadian Biologics |
|
Peter Brenders, President and CEO, BIOTECanada |
| |
| |
11:15 AM |
Biologic Vaccines |
Increasing Awareness Of Requirements For Pandemic Planning And Preparedness |
|
Harold Rode, Chief, Pandemic Influenza Division, Centre for Biologics Evaluation, BGTD, Health Canada |
| |
| |
12:00 PM |
Networking Luncheon |
Sponsored by Sampling Technologies. |
|
| |
| |
1:30 PM |
Determining The Impact Of WHO’s Global Vaccination Program On Canada’s Biologics Manufacturers |
|
Jerry Calver, President, Calver Biologics Consulting |
| |
| |
2:15 PM |
Opening The Patient Pathway To Your Biologic For Improved Compliance And Outcomes |
|
Martin Esterhammer, President, Calea HealthAccess |
| |
| |
3:00 PM |
Networking Break |
| |
| |
3:30 PM |
Assessing The Impact Of Design Space And Quality By Design On Your Business |
|
Jeffrey Hartry, Director, Quality Systems and Information, Cangene Corporation |
| |
| |
4:15 PM |
Winning Strategies For Niche Pharma Products Throughout The Product’s Lifecycle |
|
Craig Martin, President, Cameron Stewart LifeScience Inc. |
| |
| |
5:00 PM |
Conference Adjourns To Day Two |
| |
| |
| |
Day Two:
Wednesday June 11th, 2008 |
| |
7:30 AM |
Registration Opens |
| |
| |
8:15 AM |
Recap Of Day One By The Chair |
| |
| |
8:30 AM |
| Common Drug Review: The Next Steps For Biologics In Sustainable Canadian Public Drug Plans |
|
Mike Tierney, VP, Common Drug Review, Canadian Agency for Drugs and
Technologies in Health |
| |
| |
9:15 AM |
Panel Discussion |
Evaluating The Current And Future Challenges Of Biologics For The Private Payer Industry |
Blair Coffin, Team Leader Actuarial Pricing, Medavie Blue Cross
Bob Kamino, Vice President, Consulting Services, Brogan Inc.
Kevin O’Connor, Director, Federal and Private Healthcare, Janssen-Ortho and Ortho Biotech |
| |
| |
10:00 AM |
Networking Break |
| |
| |
10:30 AM |
| Optimizing Cost Reimbursement Strategies To Make The Most Of The Benefits Of Biologics |
|
Wayne Critchley, Partner, Gowling Lafleur Henderson, former Executive Director, Patented Medicine Prices Review Board |
| |
| |
11:15 AM |
Reimbursement Panel |
Putting The Pieces Together: Developing An Integrated Reimbursement Plan For Your Biologic |
|
Mike Tierney, VP, Common Drug Review, Canadian Agency for Drugs and Technologies in Health
Wayne Critchley, Partner, Gowling Lafleur Henderson
Blair Coffin, Team Leader Actuarial Pricing, Medavie Blue Cross
Bob Kamino, Vice President, Consulting Services, Brogan Inc.
Kevin O’Connor, Director, Federal and Private Healthcare, Janssen-Ortho and Ortho Biotech |
| |
| |
12:00 PM |
Networking Luncheon |
| |
| |
1:30 PM |
Case Study: EMD Serono |
Achieving And Expanding Market Access For Breakthrough Biologics |
|
Robert Kulik, Director, Market Access and Government Affairs, EMD Serono Canada Inc. |
| |
| |
2:15 PM |
Optimizing Patient Education And Adherence With Real Time Measures For Biologics |
|
Jason Steele, Director of Marketing and Strategic Partnerships, Sampling Technologies, Inc. |
| |
| |
3:00 PM |
Networking Break |
| |
| |
3:30 PM |
Case Study: Hoffmann-La Roche And Cancer Care Ontario |
Collaborating To Optimize Patient Access: Two Perspectives |
|
David Shum, Director, Reimbursement Strategy and Health Economics, Hoffmann-La Roche Canada
Scott Gavura, Director, Provincial Drug Reimbursement Programs, Cancer Care Ontario |
| |
| |
4:15 PM |
Patient Biologics Registries |
Bridging The Gap Between Progressive Licensing And Appropriate Patient Access |
|
Durhane Wong-Rieger, President, Canadian Organization for Rare Disorders |
| |
| |
5:00 PM |
Conference adjourns |
| |
